SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
0.539
-0.060 (-9.95%)
At close: Jan 21, 2025, 4:00 PM
0.530
-0.009 (-1.74%)
Pre-market: Jan 22, 2025, 7:47 AM EST
SciSparc Revenue
SciSparc had revenue of $840.00K in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to $1.75M, down -47.36% year-over-year. In the year 2023, SciSparc had annual revenue of $2.88M with 113.73% growth.
Revenue (ttm)
$1.75M
Revenue Growth
-47.36%
P/S Ratio
0.40
Revenue / Employee
$582,333
Employees
3
Market Cap
1.93M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
SPRC News
- 7 days ago - SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - GlobeNewsWire
- 8 days ago - SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles - GlobeNewsWire
- 15 days ago - SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results - GlobeNewsWire
- 15 days ago - Why Is Psychedelic-SciSparc Stock Trading Higher On Monday? - Benzinga
- 16 days ago - SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment - GlobeNewsWire
- 21 days ago - SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder - GlobeNewsWire
- 26 days ago - S&P 500 Edges Lower, SciSparc Shares Surge - Benzinga
- 27 days ago - SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation - GlobeNewsWire